Redhill Biopharma Company Leadership
RDHL Stock | USD 2.99 0.19 6.79% |
Redhill Biopharma employs about 53 people. The company is managed by 15 executives with a total tenure of roughly 64 years, averaging almost 4.0 years of service per executive, having 3.53 employees per reported executive. Inspection of Redhill Biopharma's management performance can provide insight into the company performance.
Dror BenAsher Chairman Chairman of the Board, CEO |
Rick Scruggs President President Officer |
Redhill |
Redhill Biopharma's Workforce Through the Years
Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Redhill Biopharma's future performance. Based on our forecasts, it is anticipated that Redhill will maintain a workforce of about 50 employees by April 2025.Redhill Biopharma Management Team Effectiveness
The company has return on total asset (ROA) of (0.4488) % which means that it has lost $0.4488 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (17.0861) %, meaning that it created substantial loss on money invested by shareholders. Redhill Biopharma's management efficiency ratios could be used to measure how well Redhill Biopharma manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is expected to rise to 1.29 this year. Return On Capital Employed is expected to rise to 3.14 this year. At this time, Redhill Biopharma's Other Assets are quite stable compared to the past year. Return On Tangible Assets is expected to rise to 1.29 this year, although the value of Other Current Assets will most likely fall to about 2.3 M.Common Stock Shares Outstanding is expected to rise to about 7.8 M this year, although the value of Net Loss is projected to rise to (83.6 M).
Redhill Biopharma Workforce Comparison
Redhill Biopharma is rated below average in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 3,066. Redhill Biopharma claims roughly 53.0 in number of employees contributing just under 2% to equities under Health Care industry.
Redhill Biopharma Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Redhill Biopharma Price Series Summation is a cross summation of Redhill Biopharma price series and its benchmark/peer.
Redhill Biopharma Notable Stakeholders
A Redhill Biopharma stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Redhill Biopharma often face trade-offs trying to please all of them. Redhill Biopharma's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Redhill Biopharma's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Dror BenAsher | Chairman of the Board, CEO | Profile | |
Rick Scruggs | President Officer | Profile | |
Adi Frish | Sr. VP of Bus. Devel. and Licensing | Profile | |
Reza Fathi | Senior Development | Profile | |
Kristin Comer | G VP | Profile | |
Valerie Graceffa | VP Sales | Profile | |
Razi Ingber | Chief Officer | Profile | |
Rob Jackson | VP Marketing | Profile | |
Micha BenChorin | Chief Officer | Profile | |
Patricia RAC | Senior Affairs | Profile | |
MSc MPhil | Chief Officer | Profile | |
FACP MD | Chief Officer | Profile | |
Guy Goldberg | Chief Business Officer | Profile | |
Alexandra Okmian | Senior Manager | Profile | |
Guy JD | Chief Officer | Profile |
About Redhill Biopharma Management Performance
The success or failure of an entity such as Redhill Biopharma often depends on how effective the management is. Redhill Biopharma management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Redhill management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Redhill management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | 1.23 | 1.29 | |
Return On Capital Employed | 2.99 | 3.14 | |
Return On Assets | 0.93 | 0.98 | |
Return On Equity | 10.40 | 10.92 |
Redhill Biopharma Workforce Analysis
Traditionally, organizations such as Redhill Biopharma use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Redhill Biopharma within its industry.Redhill Biopharma Manpower Efficiency
Return on Redhill Biopharma Manpower
Revenue Per Employee | 122.9K | |
Revenue Per Executive | 434.2K | |
Net Income Per Employee | 451.2K | |
Net Income Per Executive | 1.6M |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Redhill Biopharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. For more information on how to buy Redhill Stock please use our How to buy in Redhill Stock guide.You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Redhill Biopharma. If investors know Redhill will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Redhill Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (302.63) | Revenue Per Share | Quarterly Revenue Growth (0.28) | Return On Assets | Return On Equity |
The market value of Redhill Biopharma is measured differently than its book value, which is the value of Redhill that is recorded on the company's balance sheet. Investors also form their own opinion of Redhill Biopharma's value that differs from its market value or its book value, called intrinsic value, which is Redhill Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Redhill Biopharma's market value can be influenced by many factors that don't directly affect Redhill Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Redhill Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Redhill Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Redhill Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.